Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05776316 · ClinicalTrials.gov registry record · NA
Harm Reduction Services
A NA study of Substance Abuse and Drug Use, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 3
- Study locations
NCT05776316 is a NA study of Substance Abuse and Drug Use that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 200 participants, below the 5,256-participant average among 58 other Substance Abuse trials with a reported enrollment target (96% lower). The trial reports 3 study locations across 2 states.
The verdict
NCT05776316, a NA study of Substance Abuse and Drug Use, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to assess whether an integrated harm reduction intervention (IHRI), compared to harm reduction (HR) services as usual, will improve harm reduction service utilization among Black and Latinx people who use drugs (PWUD).
Conditions Studied
Interventions
- BEHAVIORAL Integrated Harm Reduction Intervention (IHRI)
Study Locations (3)
New York
- NYU Langone Health - New York
- Nathan Kline Institute - Orangeburg
Connecticut
- Yale University - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-11-25 |
| Est. Completion | 2028-03-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05776316
The ClinicalTrials.gov registry entry for NCT05776316 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,256-participant average among 58 other Substance Abuse trials with a reported enrollment target (96% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Substance Abuse appearing as the primary indexed condition, and to 1 intervention - of which Integrated Harm Reduction Intervention (IHRI) is the first listed.
NCT05776316 reports 3 study locations spanning 2 distinct geographic areas - top geographies include New York, Connecticut.
Frequently Asked Questions
What is clinical trial NCT05776316 about?
NCT05776316 is a clinical study titled "Harm Reduction Services". The purpose of this study is to assess whether an integrated harm reduction intervention (IHRI), compared to harm reduction (HR) services as usual, will improve harm reduction service utilization among Black and Latinx people who use drugs (PWUD).
What is the current status of trial NCT05776316?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2024-11-25. Estimated completion is 2028-03-28.
What conditions does trial NCT05776316 study?
This clinical trial studies the following conditions: Substance Abuse, Drug Use, Mental Illness.
What interventions are being tested in trial NCT05776316?
The interventions under investigation include: Integrated Harm Reduction Intervention (IHRI) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05776316?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05776316 being conducted?
This trial has 3 study locations across Connecticut, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Abuse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Functional Connectivity Alterations in Suicidal Patients Among Opioid Users
RECRUITING · NA
-
Testing ALERT With GTO in Middle Schools
RECRUITING · NA
-
Testing Strategies to Improve Substance Misuse Prevention Research Use in State Policy Contexts
RECRUITING · NA
-
The STop UNhealthy Substance Use Now Trial
RECRUITING · NA
-
The Trans-Led Care Study
RECRUITING · NA
-
Data2Action Oregon Project: Supporting Data-driven Decision-Making for Substance Use Services, Policy, and Overdose Prevention
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.